Skip to content

OS Therapies Inc

OSTX· NYSECore metricsCIK 1795091

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -15.33%
Market cap
$35.31M
47.07M shares
Filings
248
—
—
—
-$11.28M
Q3 2026N/M FY25 yoy
-$9.03M
Q3 2026N/M FY25 yoy
-$14.70M
FY 2025derived
—
-$0.23
Q3 2026N/M FY25 yoy
$431.82K
Q3 2026−95.1% FY25 yoy
$35.31M
—
—
—
-41.65%
—

FY2025 figures · derived

Price

$0.750160.52%$1.1499past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$16.36MFY 2025
$16.36M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$16,360,725reported
FY 20242024-12-31$2,839,060reported
FY 20232023-12-31$3,216,933reported

Segments

Segments
Operating income by Segments, FY2023 to FY2025FY2023FY2024FY2025
LineFY2025ShareChange
CODM-$28.71M—N/M
Operating Segment———
Total-$28.71M

From the 10-K filed Mar 31, 2026OSTX

Pharmaceutical preparations

OS Therapies Inc is the 355th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

OS Therapies Inc · CIK 1795091 · Engraved from SEC EDGAR